Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 15, Issue 10, Pages 1342-1352
Publisher
Oxford University Press (OUP)
Online
2013-09-20
DOI
10.1093/neuonc/not077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
- (2015) Benjamin Le Calvé et al. NEOPLASIA
- Identification of a Dynamic Mitochondrial Protein Complex Driving Cholesterol Import, Trafficking, and Metabolism to Steroid Hormones
- (2012) Malena B. Rone et al. MOLECULAR ENDOCRINOLOGY
- Destabilization of the Outer and Inner Mitochondrial Membranes by Core and Linker Histones
- (2012) Annunziata Cascone et al. PLoS One
- Mitochondrial dysfunction in ataxia-telangiectasia
- (2011) Y. A. Valentin-Vega et al. BLOOD
- Bioenergetics Pathways and Therapeutic Resistance in Gliomas: Emerging Role of Mitochondria
- (2011) Corinne E. Griguer et al. CURRENT PHARMACEUTICAL DESIGN
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
- (2011) A. L. Rivera et al. NEURO-ONCOLOGY
- Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
- (2010) Massimo Squatrito et al. CANCER CELL
- Resistance to platinum-based chemotherapy in lung cancer cell lines
- (2010) Jianli Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inhibition of ATM kinase activity does not phenocopy ATM protein disruption
- (2010) Serah Choi et al. CELL CYCLE
- Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
- (2010) Claudia R. Oliva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells
- (2010) H.-Y. Fang et al. JOURNAL OF CELL SCIENCE
- The Calcium-Dependent Interaction between S100B and the Mitochondrial AAA ATPase ATAD3A and the Role of This Complex in the Cytoplasmic Processing of ATAD3A
- (2010) Benoît Gilquin et al. MOLECULAR AND CELLULAR BIOLOGY
- All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
- (2010) M. Labussiere et al. NEUROLOGY
- Autophagy and Metabolism
- (2010) J. D. Rabinowitz et al. SCIENCE
- IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
- (2009) S. Nobusawa et al. CLINICAL CANCER RESEARCH
- Cytoplasmic ATM in Neurons Modulates Synaptic Function
- (2009) Jiali Li et al. CURRENT BIOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Chromosome 1p and 19q Deletions in Glioblastoma Multiforme
- (2009) David Kaneshiro et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties
- (2008) Arnaud Hubstenberger et al. EXPERIMENTAL CELL RESEARCH
- Histone H2AX is a critical factor for cellular protection against DNA alkylating agents
- (2008) J A Meador et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started